A new advance in HIV treatment could pave the way toward curing the disease, researchers say.
A study has found that the antifungal drug Ciclopirox kills HIV in cell cultures -- and the virus doesn't bounce back when the drug is stopped. But the research has yet to be performed on people.
Researchers say they have determined the precise chemical structure of the HIV capsid, a protein shell that protects HIV's genetic material and enables it to debilitate the immune system.
Doctors say that a toddler born with HIV shows no signs of the virus a year after being removed from antiretroviral therapy.
Researchers at McGill University report that their comparison of five previous studies shows an accuracy difference of less than 2 percent between blood and saliva HIV tests.
A new vaccination approach out of CalTech focuses on providing protective antibodies upfront, rather than designing substances that will provoke an effective immune response.
Researchers say their 3D point-of-care sensor, called oPad, can be printed on a simple office printer.
U.K. researchers announce approval to launch the first human clinical trial of a genetically modified anti-HIV microbicide called P2G12, grown in Germany.
The Insti HIV Rapid Antibody Test, which detects antibodies to the virus in just a minute, may now be sold in the States; it is already available in more than 50 countries.
In what could be a boon in the fight against HIV, a new study of 402 people in an ER reveals that the untrained can administer HIV tests as well as health care workers.